ARTICLE | Clinical News
Anatabine citrate: Phase I data
November 2, 2015 8:00 AM UTC
A 3-part, U.K. Phase I trial in healthy volunteers showed that oral anatabine citrate was generally well tolerated with no serious adverse events reported. In part 1, subjects received single doses of...